USPTO trademark

QAMZEBRY

RegisteredUSPTOWord markClass 5

"QAMZEBRY" is a word mark owned by Glaxo Group Limited, filed at the USPTO on April 9, 2025. It is registered and covers class 5 (Pharmaceuticals).

View Glaxo Group Limited portfolio Get this data via the API

Data current as of November 18, 2025Official USPTO record

As filed with the USPTO

Status: Registered; Since November 18, 2025
Filed: April 9, 2025
Registered: November 18, 2025
Priority date: March 28, 2025; Claimed from United Kingdom
Application no.: 99127880
Registration no.: 8032560
Office: USPTO; United States Patent and Trademark Office
Mark type: Word mark; 1 class

Ownership

Who owns QAMZEBRY

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Glaxo Group Limited

Stevenage, United Kingdom

19,383 trademarks in the portfolioView company

Representative

Elizabeth K. Rucki

GSK

Goods and services

What the mark covers

The products and services QAMZEBRY is filed for, grouped by Nice class.

05Class 5 · Pharmaceuticals
Vaccines; Anti-infectives; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases

History

What has happened so far

Steps recorded by the USPTO, newest first.

November 18, 2025Notice of registration confirmation emailed
November 18, 2025Registered-principal register
September 30, 2025Official gazette publication confirmation e-mailed
September 30, 2025Published for opposition
September 24, 2025Notification of notice of publication e-mailed
August 28, 2025Approved for pub - principal register
August 26, 2025Assigned to examiner
July 25, 2025Teas amendment entered before attorney assigned
July 25, 2025Teas voluntary amendment received
April 9, 2025New application office supplied data entered

2 earlier steps on the official record.

FAQ

About QAMZEBRY

Who owns the trademark "QAMZEBRY"?

The USPTO trademark "QAMZEBRY" (application 99127880) is owned by Glaxo Group Limited.

What is the status of "QAMZEBRY"?

Its status at the USPTO is: registered.

When was "QAMZEBRY" registered?

It was registered on November 18, 2025.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull QAMZEBRY and marks like it into your own product with one request.

GET/v1/trademarks/{id}
The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/events
Every step in the office history
GET/v1/proceedings?trademark_id={id}
Oppositions and cancellations against the mark

Get API key View docs

GET /v1/trademarks/{id}

ID=tm_019d2aa8-1d9c-778d-bd1b-67686d7faf56
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"

Response

{
  "id": "tm_019d2aa8-1d9c-778d-bd1b-67686d7faf56",
  "object": "trademark",
  "mark_text": "QAMZEBRY",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "99127880",
  "filing_date": "2025-04-09",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Glaxo Group Limited",
      "entity_id": "ent_019eb6f6-4cb9-77ae-916f-63b3231a6d3d"
    }
  ]
}